Associate Professor
University of California, San Francisco, California, United States
Dr. Mousawi directs the Translational Neuropsychiatry Through Neuromodulaton (TN²) laboratory, which investigates the neurobiology of substance use disorders and uses neuromodulation tools such as Low-Intensity Focused Ultrasound (LIFU), Transcranial Magnetic Stimulation (TMS), and Deep Brain Stimulation (DBS) to treat drug and alcohol addiction. The goal of the lab is to identify neural biomarkers of craving and drug-seeking behaviors and leverage those findings to develop individualized clinical treatments with neuromodulation.
Low Intensity Focused Ultrasound Neuromodulation: The Premise and Promise
Thursday, January 30, 2025
1:30 PM - 2:00 PM EST
Thursday, January 30, 2025
4:00 PM - 5:00 PM EST